Neogen Corporation

Informe acción NasdaqGS:NEOG

Capitalización de mercado: US$2.7b

Neogen Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de Neogen han disminuido a una tasa media anual de -37.7%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido creciendo a una tasa media de 18.8% al año. La rentabilidad financiera de Neogen es de 0.05%, y sus márgenes netos son de 0.2%.

Información clave

-37.7%

Tasa de crecimiento de los beneficios

-37.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 8.9%
Tasa de crecimiento de los ingresos18.8%
Rentabilidad financiera0.05%
Margen neto0.2%
Última actualización de beneficios29 Feb 2024

Actualizaciones de resultados anteriores recientes

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Recent updates

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Apr 15

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Mar 29
Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Mar 26

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12
Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Jan 09
Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Dec 06
Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Jul 12
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Jun 20
Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Mar 25
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Oct 10

Neogen GAAP EPS of $0.05, revenue of $132.35M

Sep 27

Neogen drops 9% as merger with 3M’s food safety business closes

Sep 01

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Aug 21
Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Neogen: Cut In Half, Still Some Questions

Aug 12

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Aug 04
There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Aug 01

Neogen FQ4 2022 Earnings Preview

Jul 25

Zoetis, IDEXX named as buys in animal health space by Piper Sandler

Jul 13

Neogen announces pricing of $350M senior notes offering

Jul 07

Neogen: Safety Food Giant In The Making

Dec 15

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Dec 12
Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Sep 12
Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Robust Valuation Leaves Neogen Little Room For Error After Mixed Results

Jul 27

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Neogen. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:NEOG Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
29 Feb 24929232224
30 Nov 239191235427
31 Aug 23919-2733628
31 May 23822-2328426
28 Feb 23721-1326723
30 Nov 22631-1618520
31 Aug 225313614518
31 May 225274814217
28 Feb 225144915417
30 Nov 215035713317
31 Aug 214876212817
31 May 214686112216
28 Feb 214506112016
30 Nov 204336011415
31 Aug 204266111315
31 May 204185911415
29 Feb 204195911415
30 Nov 194176011214
31 Aug 194166011214
31 May 194146011113
28 Feb 194136210911
30 Nov 184106510911
31 Aug 184036610711
31 May 183986310511
28 Feb 183895810411
30 Nov 173825210211
31 Aug 17372469911
31 May 17358449410
28 Feb 17353419510
30 Nov 16341399310
31 Aug 16330379010
31 May 16321378710
29 Feb 16310368410
30 Nov 15301358110
31 Aug 15290347910
31 May 15283347710
28 Feb 1527232759
30 Nov 1426531759
31 Aug 1425629739
31 May 1424728718
28 Feb 1423628688
30 Nov 1322528658
31 Aug 1321628638
31 May 1320827618

Ingresos de calidad: NEOG has a large one-off loss of $63.7M impacting its last 12 months of financial results to 29th February, 2024.

Margen de beneficios creciente: NEOG became profitable in the past.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: NEOG's earnings have declined by 37.7% per year over the past 5 years.

Acelerando crecimiento: NEOG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Beneficios vs. Industria: NEOG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de NEOG (0.05%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target